Patent application number | Description | Published |
20120090365 | Organic Soil Amendments And Method For Enhancing Plant Health - An organic soil amendment comprises a live aerobic culture of beneficial microorganisms, comprising beneficial bacteria and fungi, and additives and plant extracts. The present invention also provides a method for producing an organic soil amendment by extracting beneficial microorganism at least in part from a compost comprising green and brown plant waste, and is free of manure. The extracted beneficial microorganism is amplified, while additional beneficial microorganism maybe added. Plant extracts and other additives are added to the live beneficial microorganism culture. The present invention further provides a method for storing and transporting the organic soil amendment at a reduced temperature, such as refrigeration, freezing, or lyophilizing. In addition, the present invention provides a method for maintaining the viability of the organic soil amendment in a ready to use form. | 04-19-2012 |
20140138407 | Organic Soil Amendments Storage And Dispensing System - The present invention provides a fluid storage and dispensing system for an organic soil amendment concentrate or fertilizer, comprises a storage tank, which comprises a fluid inlet and a fluid outlet, wherein the storage tank is refrigerated, a first flow meter connecting the fluid outlet of the storage tank on one end and a product tank on the other end, a second flow meter connecting to a water supply line on one end, an eductor connecting to the second flow meter on one end and the product tank on the other end, wherein the a concentrate stored in the storage tank is metered in via the first flow meter and mixed in the product tank with water metered via the second flow meter. As one aspect of the invention, the storage tank comprises interconnected holding tanks that are re-circulated. At least one water tank may be included between the water supply and the second flow meter. | 05-22-2014 |
Patent application number | Description | Published |
20090274765 | Compositions and Methods for Drug Delivery - The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises an opsonin, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm. | 11-05-2009 |
20100086611 | Method for Treating Infectious Organisms Normally Considered to be Resistant to an Antimicrobial Drug - The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 μm as measured by laser diffractometry. | 04-08-2010 |
20100290983 | Compositions and Methods for Drug Delivery - The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises a surfactant having formula I, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm: | 11-18-2010 |
20120070498 | Submicron Particles of Antineoplastic Agents - The present invention is concerned with the formation of submicron particles of an antineoplastic agent, particularly paclitaxel, by precipitating the antineoplastic agent in an aqueous medium to form a pre-suspension followed by homogenization. Surfactants with phospholipids conjugated with a water soluble or hydrophilic polymer such as PEG are used as coating for the particles. The particles produced generally have an average particle size of less than about 1000 nm and are not rapidly soluble. | 03-22-2012 |
20120277309 | METHODS OF CONTROLLING VENOUS IRRITATION ASSOCIATED WITH THE TREATMENT OF A CARDIAC DISORDER - A pharmaceutical composition comprising (S)-methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate in a concentration between about 75 mM and about 150 mM, which is substantially free of the R-isomer or pharmaceutically acceptable salt thereof, is provided. A method of treating a cardiac disorder is also provided and includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising (S)-methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride, wherein the (S)-methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride is present at a concentration between about 75 mM and about 150 mM and wherein the pharmaceutical composition is substantially free of (R)-methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate or pharmaceutically acceptable salt thereof. | 11-01-2012 |
20120302637 | Methods of Treating Tachycardia and/or Controlling Heart Rate While Minimizing and/or Controlling Hypotension - A method of treating tachycardia while minimizing and/or controlling hypotension associated with such treatment includes administering a therapeutically effective amount of a pharmaceutical composition comprising the S-isomer of esmolol to a subject in need thereof. | 11-29-2012 |
20140066503 | METHODS FOR TREATING TACHYCARDIA AND/OR CONTROLLING HEART RATE WHILE MINIMIZING AND/OR CONTROLLING HYPOTENSION - A method of treating tachycardia while minimizing and/or controlling hypotension associated with such treatment includes administering a therapeutically effective amount of a pharmaceutical composition comprising the S-isomer of esmolol to a subject in need thereof. | 03-06-2014 |
20150024031 | Methods And Compositions For Reducing Pain, Inflammation, And/Or Immunological Reactions Associated With Parenterally Administering A Primary Therapeutic Agent - Disclosed herein are methods and pharmaceutical compositions for reducing the pain associated with parenterally administering a therapeutic agent. The methods and compositions comprise a dispersion comprising microparticles of an analgesic agent in an amount effective to reduce the pain, inflammation, and/or immunological reaction associated with parenterally administering a primary therapeutic agent, wherein the microparticles of the analgesic agent have an effective particle size of less than 20 micrometers. | 01-22-2015 |